| 15. |
Income Taxes |
Income taxes reported differ from the amount computed by applying the statutory rates to net income (losses). The reasons are as follows:
| 2017 | 2016 | ||||||
| Statutory income taxes | $ | (794 | ) | $ | (305 | ) | |
| Net operating losses for which no tax benefits have been recorded | 346 | 201 | |||||
| Deficiency of depreciation over capital cost allowance | (235 | ) | (206 | ) | |||
| Non-deductible expenses | 239 | 105 | |||||
| Undeducted research and development expenses | 525 | 245 | |||||
| Investment tax credit | (81 | ) | (40 | ) | |||
| $ | - | $ | - |
The major components of the deferred tax assets classified by the source of temporary differences are as follows:
| 2017 | 2016 | ||||||
| Leasehold improvements and equipment | $ | 252 | $ | 201 | |||
| Net operating losses carryforward | 2,620 | 2,062 | |||||
| Undeducted research and development expenses | 2,054 | 1,501 | |||||
| Non-refundable tax credits carryforward | 1,553 | 1,190 | |||||
| 6,479 | 4,954 | ||||||
| Valuation allowance | (6,479 | ) | (4,954 | ) | |||
| $ | - | $ | - |
As at December 31, 2017, management determined that enough uncertainty existed relative to the realization of deferred income tax asset balances to warrant the application of a full valuation allowance. Although management believes that certain of the net operating losses will be applied against earnings in 2018, management continues to believe that enough uncertainty exists relative to the realization of the remaining deferred income tax asset balances such that no recognition of deferred income tax assets is warranted.
There were Canadian and provincial net operating losses of approximately $9,560 thousand (2016: $7,585 thousand) and $10,052 thousand (2016: $7,763 thousand) respectively, that may be applied against earnings of future years. Utilization of the net operating losses is subject to significant limitations imposed by the change in control provisions. Canadian and provincial losses will be expiring between 2027 and 2037. A portion of the net operating losses may expire before they can be utilized.
As at December 31, 2017, the Company had non-refundable tax credits of $1,553 thousand (2016: $1,190 thousand) of which $8 thousand is expiring in 2026, $10 thousand is expiring in 2027, $180 thousand is expiring in 2028, $158 thousand is expiring in 2029, $134 thousand is expiring in 2030, $143 thousand is expiring in 2031, $179 thousand is expiring in 2032, $119 thousand is expiring in 2033, $90 thousand expiring in 2034, $106 thousand is expiring in 2035, $146 thousand expiring in 2036 and $280 thousand is expiring in 2037 and undeducted research and development expenses of $7,532 thousand (2016: $5,438 thousand) with no expiration date.
The deferred tax benefit of these items was not recognized in the accounts as it has been fully provided for.
Unrecognized Tax Benefits
The Company does not have any unrecognized tax benefits.
Tax Years and Examination
The Company files tax returns in each jurisdiction in which it is registered to do business. For each jurisdiction a statute of limitations period exists. After a statute of limitations period expires, the respective tax authorities may no longer assess additional income tax for the expired period. Similarly, the Company is no longer eligible to file claims for refund for any tax that it may have overpaid. The following table summarizes the Company’s major tax jurisdictions and the tax years that remain subject to examination by these jurisdictions as of December 31, 2017:
| Tax Jurisdictions | Tax Years | |
| Federal - Canada | 2014 and onward | |
| Provincial - Quebec | 2014 and onward | |
| Federal - USA | 2014 onward |